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Background: Cardiac arrhythmias represent a significant problem globally, leading to
cerebrovascular accidents, myocardial infarction, and sudden cardiac death. There is
increasing evidence to suggest that increased oxidative stress from reactive oxygen
species (ROS), which is elevated in conditions such as diabetes and hypertension, can
lead to arrhythmogenesis.
Method: A literature review was undertaken to screen for articles that investigated the
effects of ROS on cardiac ion channel function, remodeling and arrhythmogenesis.
Results: Prolonged endoplasmic reticulum stress is observed in heart failure, leading
to increased production of ROS. Mitochondrial ROS, which is elevated in diabetes and
hypertension, can stimulate its own production in a positive feedback loop, termed
ROS-induced ROS release. Together with activation of mitochondrial inner membrane
anion channels, it leads to mitochondrial depolarization. Abnormal function of these
organelles can then activate downstream signaling pathways, ultimately culminating
in altered function or expression of cardiac ion channels responsible for generating
the cardiac action potential (AP). Vascular and cardiac endothelial cells become
dysfunctional, leading to altered paracrine signaling to influence the electrophysiology
of adjacent cardiomyocytes. All of these changes can in turn produce abnormalities in
AP repolarization or conduction, thereby increasing likelihood of triggered activity and
reentry.
Conclusion: ROS plays a significant role in producing arrhythmic substrate.
Therapeutic strategies targeting upstream events include production of a strong reducing
environment or the use of pharmacological agents that target organelle-specific proteins
and ion channels. These may relieve oxidative stress and in turn prevent arrhythmic
complications in patients with diabetes, hypertension, and heart failure.
Keywords: oxidative stress, reactive oxygen species, endoplasmic reticulum, mitochondria, conduction,
repolarization, remodeling, arrhythmia
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INTRODUCTION
Cardio-metabolic disorders such as diabetes mellitus and
hypertension place significant burdens on the healthcare system
worldwide. Over the past decades, their prevalence has been
steadily increasing, due to aging and a rising level of obesity
in the population (Chan and Woo, 2010; Wong et al.,
2011). These disorders are leading causes of mortality and
morbidity, which are traditionally attributed to cardiovascular
accidents, myocardial infarction, and heart failure. Cardiac
arrhythmias have increasingly been recognized as a cause
of death. Diabetes may affect the prognosis of heart failure
subjects differently at the clinical (Sardu et al., 2014b) and
epigenetic level (Sardu et al., 2016). This article explores
the normal functions of the endoplasmic reticulum (ER) and
mitochondria, and synthesize current experimental data to
illustrate how increased oxidative andmetabolic stress can lead to
dysfunction of these organelles, and in turn can initiate signaling
cascades that modify the ion channel function and promote
electrophysiological and structural remodeling, which ultimately
promotes arrhythmogenesis.
NORMAL FUNCTIONS OF THE
ENDOPLASMIC RETICULUM,
SARCOPLASMIC RETICULUM, AND
MITOCHONDRIA
The ER is the intracellular organelle responsible for protein
synthesis, folding, maturation, and assembly before they are
exported to the Golgi apparatus, cytosol and plasma membrane.
The oxidative environment within the lumen ensures proper
formation of tertiary and quaternary structures, aided by
chaperones and abundance of Ca2+ for interactions between
them. Abnormalities in these factors can lead to unfolding
or misfolding of proteins, which in turn can accumulate
within the ER lumen. This would produce ER stress and
elicit the unfolded protein response (UPR), which serves to
reduce protein synthesis, enhance protein folding ability and aid
misfolded or unfolded protein to cellular degradation pathways
(Tsang et al., 2010).
The sarcoplasmic reticulum (SR) of cardiomyocytes is
responsible for excitation-contraction coupling and subsequent
contractile activation. Thus, dihydropyridine receptors (DIHRs)
are found in the transverse tubular system and have molecular
configurations that are steeply voltage-dependent, enabling them
to act as voltage sensors. They are allosterically coupled to RyRs,
the Ca2+ release channels in the SR. A depolarizing wave from the
plasma membrane can spread to the transverse tubules, thereby
activating the DIHRs, which then allows RyRs to dissociate from
DIHRs and release the luminal Ca2+, inducing further release
from the SR by a mechanism called Ca2+-induced Ca2+-release.
This intracellular Ca2+ is important for initiation of contractile
activity, as it binds to Ca2+-sensitive proteins including troponin,
myosin, and actin. Relaxation occurs when intracellular Ca2+
returns to normal levels by following mechanisms: passive eﬄux
mediated by the electrogenic sodium-calcium exchanger (NCX)
out of the cell, active transport into the SR by sarcoplasmic
reticulum Ca2+-ATPase (SERCA) and passive diffusion into the
mitochondria via the mitochondrial Ca2+ uniporter (Choi et al.,
2014). Finally, the SR may have functions that are traditionally
ascribed to the ER, such as protein synthesis and folding
(Glembotski, 2012).
The mitochondria are the site of energy supply where ATP
synthesis occurs by oxidative phosphorylation, with additional
roles such as regulation of apoptosis, redox status and reactive
oxygen species (ROS) production (Dikalov, 2011). ATP synthesis
involves electron transfer through the respiratory chain from
complex I through to complex IV, culminating in protons being
pumped from the mitochondrial matrix into the intermembrane
space (Chance and Williams, 1955). Mitochondria are the main
source of ROS, which are derived mostly from complexes I
and III, as well as enzymes such as the alpha-ketoglutarate
dehydrogenase complex and those involved in fatty acid beta-
oxidation (St-Pierre et al., 2002; Starkov et al., 2004; Tahara
et al., 2009; Brand, 2010). Oxygen free radical production is
much more efficient by reverse electron transfer dependent on
succinate (through complex I to NAD+) than forward electron
transfer with NADH (Panov et al., 2007). This reverse electron
transfer is an important mechanism of ROS production in many
pathological conditions such as hypertension (Nazarewicz et al.,
2013).
INCREASED OXIDATIVE STRESS AND
INTRACELLULAR ORGANELLE
DYSFUNCTION IN CARDIO-METABOLIC
DISORDERS
Increased oxidative stress from excessive ROS production
appears to underlie pro-arrhythmic cardiac modeling in cardio-
metabolic disorders (Figure 1). There is an increased arrhythmic
burden, conditioning primary and secondary outcomes in
patients with metabolic syndrome (Sardu et al., 2014a). ROS
refers to superoxide, hydrogen peroxide, peroxynitrite, and
hydroxyl radicals, which are unstable molecular species that
can damage proteins and lipids within the cell, and activate
intracellular signaling cascades. They can be generated by
activation of NADPH oxidase or xanthine oxidase, uncoupling
of nitric oxide synthase (NOS) or leakage of electrons from
the mitochondria during oxidative phosphorylation. Normally,
cardiomyocytes are protected from ROS-mediated damage
by several mechanisms. Firstly, enzymes such as superoxide
dismutase (SOD), catalase and glutathione peroxidase
breakdown ROS into water and oxygen. Secondly, a series
of redox defense systems can inactivate ROS, which are reduced
glutathione (GSH), NADH, thioredoxin, and free radical
scavengers such as vitamins C and E (Schafer and Buettner, 2001;
Yamamoto et al., 2003; Zima et al., 2004; Gasparetto et al., 2005).
Abnormal NADH accumulation, observed in diabetes, can lead
to reductive stress, pseudohypoxia and subsequent, paradoxical
oxidative stress; interested readers are directed to this article
here (Yan, 2014). Increased oxidative stress is associated with
abnormal function of intracellular organelles such as the ER and
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FIGURE 1 | Signaling mechanisms linking increased reactive oxygen species (ROS) production and ion channel remodeling.
mitochondria (Wong et al., 2013; Cheang et al., 2014; Lenna
et al., 2014; Murugan et al., 2015; Zhang et al., 2015). Since
both the ER and mitochondria are associated with Ca2+ release
and uptake in cardiomyocytes and abnormal Ca2+ handling in
these cells can cause arrhythmias, it is not surprisingly that ED
could be the initial trigger. ROS can also promote structural
and electrophysiological remodeling, leading to abnormalities in
action potential (AP) conduction or repolarization (Tse and Yeo,
2015), and in turn to triggered activity or circus-type reentry
(Figure 2). These mechanisms are considered in further detail
below.
TRIGGERED ACTIVITY AND REENTRY
CAN RESULT FROM ROS GENERATION
Action Potential Prolongation and
Abnormal Ca2+ Handling Can Lead to
Triggered Activity
Triggered activity results from afterdepolarizations, which are
secondary depolarization events arising prematurely before
generation of the next AP (Cranefield, 1977; January et al.,
1991). They can occur before or after full repolarization, termed
early afterdepolarizations (EADs) or delayed afterdepolarizations
(DADs), respectively. EADs typically develop when action
potential durations (APDs) are prolonged, due to a greater
magnitude of inward depolarizing currents (INa, ICa, INCX)
compared to the outward repolarizing currents (IKr, IKs, IK1)
(Tse, 2015). This would enable reactivation of the L-type calcium
channel, thereby increasing ICa,L (January and Riddle, 1989).
By contrast, DADs occur when there is intracellular Ca2+
overload, which induces Ca2+-induced Ca2+ release from the
ER. This activates the sodium-calcium exchange current, INCX,
the nonselective cationic current, INS and the calcium-activated
chloride current, ICl,Ca (Guinamard et al., 2004). The net result
of EAD or DAD is membrane depolarization and initiation of
another AP. If the afterdepolarizations are not sufficiently large
to induce an AP, they can exacerbate the regional differences
in repolarization, which may lead to alternans, unidirectional
conduction block and reentry (Tse et al., in press).
Electrophysiological remodeling is observed in heart failure,
with mostly downregulation of ion channels, leading to APD
prolongation and/or altered calcium release, predisposing to
EADs, DADs, and reentry (Marfella et al., 2013; Tse et al., 2016a).
Moreover, the activities of ion channels may condition heart
failure and arrhythmic state, regulating epigenetic mechanisms
related to cardiac adaptive responses (Sardu et al., 2014c,
2015). The renin-angiotensin system (RAS) becomes activated
in diabetes, hypertension and heart failure. This pathway is
responsible for enzymatic cleavage of angiotensinogen, which is
converted to angiotensin I and angiotensin II (Ang-II) by renin
and angiotensin converting enzyme (ACE), respectively. Ang-II
can activate the AT1 receptor, which increases NADPH oxidase
activity to promote ROS production, resulting in downregulation
of the calcium-independent transient outward K+ channel (Ito)
(Lebeche et al., 2006). ROS can increase the activity of MAPK-
activated protein kinase-1 (p90rsk), which phosphorylates and
decreases the activity of Ito, f, IK, slow and ISS channels (Lu et al.,
2008). ROS can prolongs the late sodium current, INa,L (Ma et al.,
2005; Song Y. et al., 2006).
Moreover, prolonged activation of UPR during ER stress in
heart failure leads to increased oxidative stress, downregulation
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FIGURE 2 | Increased reactive oxygen species (ROS) production in cardio-metabolic disorders induce both conduction and repolarization
abnormalities, thereby leading to both triggered and reentrant arrhythmogenesis. UPR, unfolded protein response; RIRR, ROS-induced ROS release; 19m,
mitochondrial inner membrane potential.
of Ito and increased Ca
2+ release from the SR. RyR2, the cardiac-
specific isoform, is affected by post-translational modification
from intracellular signaling cascades. Thus, they can be oxidized
by ROS or reactive carbonyl species (RCS) (Eager et al., 1997; Xu
et al., 1998; Bidasee et al., 2003), or phosphorylation by protein
kinases such as protein kinase A or Ca2+/calmodulin-dependent
protein kinase II (CAMKII), leading to abnormal gating (Witcher
et al., 1991; Hain et al., 1995; Wehrens et al., 2004). This in
turn leads to reduced amplitude but increased frequency of Ca2+
sparks and increased RyR2 sensitivity to Ca2+ activation (Shao
et al., 2007, 2009). RyR2 decoupling from LTCCs can lead to
desynchronized Ca2+ release (Song L.S. et al., 2006). ROS derived
from the mitochondria could inhibit SERCA and stimulate RyR2,
thereby activating NCX, Ca2+-sensitive cationic channels and
Ca2+-induced Ca2+-release (Li et al., 2015).
Aside from regulation of energy production, mitochondria
can also take up and release Ca2+ through several mechanisms,
and may therefore serve as a buffer system. It may be that under
physiological conditions, mitochondria do not have a major
role in buffering Ca2+ (O’Rourke and Blatter, 2009; Williams
et al., 2013). However, in heart failure, there is significant
Ca2+ overload in both the cytoplasm and the mitochondria of
cardiomyocytes (Santulli et al., 2015b). Experiments in a mouse
model of heart failure generated by myocardial infarction, leaky
RyR2 was shown to be responsible for mitochondrial Ca2+
overload (Santulli et al., 2015b). This would lead tomitochondrial
dysfunction and increased ROS production. A recent study found
that in mice with RyR2 mutations leading to diastolic Ca2+
leak, increased RyR2 oxidation, mitochondrial dysfunction and
increased ROS production are observed, and these findings were
associated with an increase in atrial fibrillation (AF) susceptibility
(Xie et al., 2015a). Other studies also support the critical role of
increased oxidative stress in the development and maintenance
of AF. Thus, ROS from the atria correlated with the duration
and substrate of AF in goats and humans (Reilly et al., 2011).
Increasedmitochondrial oxidative stress leading to RyR2 leak has
also been observed in the ventricles of a peroxisome proliferator-
activated receptor-γ (PPARg) cardiac overexpression mouse
model (Joseph et al., 2016). The net electrophysiological effect
was AP prolongation and development of ectopic activity.
Together, all of the above mechanisms can prolong APD
and/or lead to abnormal Ca2+ release, inducing EADs and DADs
and therefore triggered activity.
Disruption of Normal AP Conduction or
Repolarization and Abnormal Ca2+
Handling Can Lead to Reentry
The conduction of cardiac APs through the workingmyocardium
has traditionally been described by the core conductor model.
This is based on the cable theory, whose equations can be derived
by applying Kirchoff’s circuit law. Conduction velocity (CV) is
determined by both passive and active properties of the cell
membrane. The passive components are axial resistance of the
myoplasm (ri), resistance of the extracellular space (ro), and
membrane capacitance (Cm). Diameter of the cardiomyocyte is
important because it alters both ri and Cm. Active membrane
properties refer to the voltage-gated conductances, mainly the
sodium current (INa) mediating the AP upstroke. This model
was subsequently modified to account for the presence of gap
junctions (Saffitz et al., 1994; Rohr, 2004). Each gap junction
consists of two connexons, which are hexameric proteins of
the connexin (Cx) subunit, mediating electrical communication
by electrotonic spread. However, it forms a high resistance
pathway that can decrease CV and produce discontinuous
propagation (Spach et al., 1981; Spach, 2003). Its expression is
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not equally distributed across the myocardium, higher numbers
are found at the ends of myocytes compared to the lateral
aspects of the cell membrane (Kumar and Gilula, 1996).
Consequently, CV is higher in the longitudinal direction than in
the transverse direction, which is termed anisotropic conduction
(Sano et al., 1959; Clerc, 1976). The role of ephaptic coupling
has been neglected until recently, involving a direct electrical
field mechanism for mediating conduction (Rhett and Gourdie,
2012; Lin and Keener, 2013; Rhett et al., 2013; Veeraraghavan
et al., 2014a,b,c; George et al., 2015; Veeraraghavan et al., 2015).
Finally, myocardial fibrosis cam reduce the coupling between
cardiomyocytes, increasing ri, and enhance the coupling between
fibroblasts and cardiomyocytes (Camelliti et al., 2004; Chilton
et al., 2007), increasing cm, both of which would reduce CV and
increase the dispersion of CV (Tse and Yeo, 2015).
Circus-type reentry occurs when an AP travels around an
obstacle and re-excites its site of origin, and requires both
conduction and repolarization abnormalities (Tse, 2015; Tse et al.,
2016d,h). Firstly, conduction velocity (CV) must be sufficiently
slowed to prevent the AP depolarization wavefront from colliding
with its repolarization wave back, where the local myocardium
is still in its effective refractory period (ERP) and cannot be
excited. If this occurs, conduction will be blocked and the AP will
extinguish, resulting in a break of the reentrant circuit. Secondly,
unidirectional conduction block must be present. Otherwise,
wavefront APs traveling in opposite directions can collide and
extinguish, thereby terminating the arrhythmia. Thirdly, an
obstacle can be a non-conducting or refractory region, arising
from structural defects such as interstitial fibrosis, or dynamically
from ectopic activity. When the excitation wavelength of the AP
wave (λ, CV × ERP) is smaller than the path length, reentry can
occur. The ERP usually coincides with the APD. Thus, reduction
in CV, APD, or ERP can promote reentry by reducing λ, whereas
increased λ reduces the likelihood of reentry (Tse et al., 2012;
Choy et al., 2016; Tse, 2016b; Tse et al., 2016c,e,f,g,h,i,k,l).
All of the above factors are influenced by ROS, altering ion
channel function and promoting extracellular matrix (ECM)
remodeling, which together would produce conduction and
repolarization abnormalities, thereby leading to reentry (Tse and
Yeo, 2015). For example, the SCN5A gene encoding for the
cardiac Na+ channels is regulated by the transcription factor
NF-κB (Shang and Dudley, 2005). Elevated angiotensin II levels
and the increased oxidative stress increase NF-κB binding to the
SCN5A promoter region, thereby decreasing its transcriptional
activity (Shang et al., 2008). Ang-II can also downregulate Cx43
and Cx40, reducing intercellular coupling (Kasi et al., 2007).
During ER stress, PERK activation downregulates the Na+
channels, although this is a non-ion channel specific effect since
Ito expression is also reduced (Gao et al., 2013). Furthermore,
abnormal Ca2+ release can have direct and indirect effects. Ca2+
can bind directly to the evolutionarily conserved EF hand motif
at the carboxyl end of the Na+ channel, thereby producing a
depolarizing shift in its voltage-dependent inactivation, which
prolongs the late sodium current, INa,L (Wingo et al., 2004;
Song Y. et al., 2006). Moreover, the Na+ channel also possesses
an IQ domain for Ca2+/ CaM binding and additionally several
serine/threonine residues amenable to phosphorylation, for
example by CaMKII (Ashpole et al., 2012), leading to channel
inactivation (Tan et al., 2002).
Ca2+ can activate protein kinase C (PKC) (Luo andWeinstein,
1993), which can phosphorylate both Na+ channels (Qu et al.,
1996) and Cx43 (Moreno et al., 1994; Kwak et al., 1995) to reduce
INa and Igap, respectively. Ca
2+ overload is also associated with
dephosphorylation of gap junctions (Huang et al., 1999), leading
to their uncoupling (Beardslee et al., 2000) and lateralization
(Smith et al., 1991; Lampe et al., 2000). Interestingly, a recent
report demonstrated that streptozotocin-induced diabetic mice
have increased phosphorylation levels of Cx43 at the serine 262
residue (Palatinus and Gourdie, 2016). Previous experiments
showed that Ser 262 phosphorylation of Cx43 is associated with
a cardiac injury-resistant state (Srisakuldee et al., 2009). Poor
myocardial healing could increase the likelihood of conduction
abnormalities, which would increase arrhythmogenicity. Finally,
homocysteine, which is raised in hypertension and diabetes,
causes EEC dysfunction and apoptosis (Miller et al., 2000;
Wei et al., 2010), suppression of superoxide dismutase and
activation of matrix metalloproteinases (MMPs) in the plasma
membrane, causing Cx43 disruption (Rosenberger et al., 2006).
Increased Ca2+ leak through the RyR2 channels results in Ca2+
alternans, which in turn can drive APD alternans and reentry
(Xie et al., 2013).
Mitochondrial ROS production is elevated in diabetes and
hypertension (Kakkar et al., 1995; Kanazawa et al., 2002; Dikalov
and Ungvari, 2013). Mitochondrial ROS can itself increase its
own production in a positive feedback loop, termed ROS-induced
ROS release (RIRR), a mechanism recently recognized as a key
initiator of mitochondrial depolarization (Zorov et al., 2000).
Thus, Ang-II can activate the AT1 receptor, which stimulates
Nox2, an enzyme that catalyzes electron transfer fromNADPH to
oxygen, generating oxygen free radicals and hydrogen peroxide.
The oxygen free radical can enter the mitochondria and activate
PKCε at the mitochondrial inner membrane (Jaburek et al.,
2006). The downstream target is mitochondrial KATP channels
(mitoKATP), resulting in reverse electron transfer from complex
II to complex I, which generates more oxygen free radicals
(Dikalov et al., 2014). The latter can be converted to hydrogen
peroxide, activating c-src (Aikawa et al., 1997) and in turn
further activating NADPH oxidases, production of free radicals
and NOS uncoupling. Mitochondrial KATP channel activation
in cardiomyocytes in diabetes led to impaired APD adaptation,
which promoted the occurrence of VT (Xie et al., 2015b). Ang-
II mediated mitochondrial ROS production can lead to c-src
activation and reduced Cx43 expression (Sovari et al., 2013).
Homocysteine can activate mitochondrial MMPs, which leads to
opening the mitochondrial permeability transition pore (MPTP)
(Moshal et al., 2008; Montaigne et al., 2013) and collapse of the
mitochondrial inner membrane potential (19m) (Brown et al.,
2010).
ROS can also activate the mitochondrial inner membrane
anion channels (IMAC) to result in mitochondrial depolarization
(Yang et al., 2010). RIRR-induced regional mitochondrial
depolarization results in the formation of a metabolic sink
(Zhou et al., 2014). Uncoupling of oxidative phosphorylation
can reverse mitochondrial ATP synthase, thereby depleting
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intracellular ATP. This causes sarcolemmal KATP activation,
increased K+ eﬄux and APD shortening (Garlid et al., 1997;
Zhou et al., 2014). Moreover, ROS can promote myocardial
fibrosis via a NOX4-mediated, ROS-ERK1/2-MAP Kinase-
dependent mechanism (Aragno et al., 2006; Kuroda et al.,
2010).
Together, the above factors can lead to reduction in CV,
together with increased repolarization gradients, can promote
unidirectional conduction block and reentry (Tse et al., in press).
ENDOTHELIAL-CARDIOMYOCYTE
COUPLING, PARACRINE SIGNALING, AND
ARRHYTHMOGENESIS
Endothelial cells form the inner lining of blood vessels, thereby
controlling vascular tone by releasing vasodilators, such as
nitric oxide (NO), prostacyclin and endothelial-dependent
hyperpolarizing factor. In the heart, cardiac endothelial cells
(CECs), including myocardial coronary endothelial cells
(MCECs) lining the coronary microvasaculature and endocardial
endothelial cells (EECs), outnumber cardiomyocytes (CM) with
a 3:1 ratio and have roles distinct from those of the vascular
endothelium, such as regulation of cardiomyocyte growth and
modulation of electrical and mechanical functions (Baldwin and
Artman, 1998; Brutsaert, 2003). They may do so in a paracrine
manner by secreting messengers such as NO, prostaglandins,
endothelin and angiotensin II. These may act on specific
receptors on the plasma membrane of cardiomyocytes (e.g.,
Ang-II binding to AT1R), diffuse through the membrane of
cardiomyocytes (in the case of gasotransmitters such as NO), or
enter via gap junctions, to activate their downstream effector.
Gap junctions are non-specific pores that also allows the spread
of molecules up to 1 kDa in molecular mass (Harris, 2001;
Weber et al., 2004). However, MCECs lack gap junctions and
their communication with surrounding cells occur by other
mechanisms.
Endothelial dysfunction is a hallmark of diabetes
mellitus, hypertension and heart disease, playing a role
in the initiation and progression of vascular dysfunction,
eventually resulting in atherosclerosis, thrombosis and
arrhythmogenesis (Wong et al., 2013). This usually refers
to dysfunction of vascular endothelial cells that include
the MCECs. However, EECs also become dysfunctional
in diabetes and hypertension (Chu et al., 1995; Popov
et al., 1996; Brutsaert, 2003). These could initiate signaling
cascades that ultimately modify ion channel function and
promote electrophysiological and structural remodeling in the
myocardium to produce an arrhythmic substrate (Miller et al.,
2002; Rosenberger et al., 2006; Moshal et al., 2008; Givvimani
et al., 2011).
CLINICAL RELEVANCE AND FUTURE
PERSPECTIVES
Reduction in oxidative stress is an attractive strategy
for preventing ROS-induced ion channel dysfunction,
electrophysiological and structural remodeling. In keeping
with this theory, exogenous application of strong reducing
agents such as hydrogen sulfide was shown to reduce cardiac
fibrosis. Increasing the expression of enzymes breaking
down free radicals, such as SOD (Dikalova et al., 2010).
Glutathione peroxidase overexpression in diabetic rat hearts
prevented adverse structural remodeling by reducing fibrosis
and improving diastolic dysfunction (Matsushima et al.,
2006). This would be expected to reduce the degree of
conduction abnormalities and thereby increase the threshold for
arrhythmogenesis.
Much of the cellular oxidative stress is derived from
the mitochondria, which promotes arrhythmogenesis (Xie
et al., 2015a). Therefore, antioxidants specifically targeting
this organelle would be a logical strategy for anti-arrhythmic
therapy. Thus, experiments in genetically modified, ACE8/8
mice with RAS activation have demonstrated therapeutic effects
of a mitochondrial-specific antioxidant, but not a general
antioxidant, in preventing ventricular arrhythmias (Sovari et al.,
2013). Altered mitochondrial bioenergetics characterized by
mitochondrial depolarization is a key initiating factor of an
adverse positive feedback loop of causing RIRR. Interestingly,
inhibition of the MPTP by cyclosporine A did not prevent
the collapse of 19m (Berkich et al., 2003), whereas IMAC
inhibition using the mitochondrial benzodiazepine receptor
did (Akar et al., 2005). Recent work has demonstrated that
patients with catecholaminergic polymorphic VT, in whom
the RyR2 is mutated and leaky, insulin secretion and glucose
metabolism were dysregulated (Santulli et al., 2015a). Since
mitochondrial Ca2+ overload is due to a leaky RyR2 (Santulli
et al., 2015b), ryanodine receptor stabilizers can be used
to reduce this leak and reduce arrhythmic burden (Lehnart
et al., 2006). ER stress is also a potential target, since
a prolonged UPR can induce adverse electrophysiological
remodeling. For example, overexpression of chaperone proteins
Grp78 and Grp94 can increase binding to UPR sensors
and abnormal proteins, in turn alleviating ER and oxidative
stress as well as Ca2+ overload (Vitadello et al., 2003;
Pan et al., 2004).
Many of the above findings have been derived from animal
models, which are amenable to genetic and pharmacological
manipulation (Tse et al., 2012; Chen et al., 2016; Tse et al.,
2016b,c,e,f,g,k, in press). In these systems, electrophysiological
consequences of ion channel mutation or dysfunction can be
examined using different recording methods such as monophasic
action potential or bipolar electrogram recordings, and optical
mapping (Vigmond and Bardakjian, 1995; Vigmond and Leon,
1999; Vigmond, 2005; Vigmond et al., 2009; Tse et al., 2016j).
Furthermore, detection of magnetic signals has been used in
clinical practice: for example magnetic resonance imaging is
excellent for characterization of cardiac structures in humans
but are less practical for use in animal studies (Vassiliou
et al., 2014; Tse et al., 2015a,b). Magnetocardiography (MCG)
can be used to diagnose and predict the risk of cardiac
arrhythmias in humans (Steinhoff et al., 2004; Sato et al.,
2012; Kwong et al., 2013; Ito et al., 2014; Yoshida et al.,
2015). A micromagnetometer array with a superconducting
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quantum interference device (SQUID) can be used for non-
contact recording of MCGs from mice and has the potential
for high-throughput use to screen for pro- or anti-arrhythmic
effects of pharmacological agents (Komamura et al., 2008). Given
the evidence presented here, it is clear that increased ROS
can lead to intracellular organelle dysfunction and arrhythmias
in cardio-metabolic disorders such as diabetes mellitus and
hypertension. It is therefore prudent that the at-risk population
is identified, which would enable early intervention to reduce
arrhythmic mortality (Cardoso et al., 2003; Salles et al., 2005;
Stettler et al., 2007; Clemente et al., 2012; Tse, 2016a,c; Tse and
Yan, 2016a,b).
Nevertheless, because of the complex nature of cardiac
spatiotemporal dynamics, a systems approach is needed to
determine the net effect of a pharmacological agent on
arrhythmogenicity. Identification of the molecular events is
important for developing therapeutic strategies to reduce
oxidative stress, which could slow or even reverse disease
progression of cardio-metabolic disorders, which would in
turn reduce the risk of cardiac arrhythmias complicating these
conditions in this patient population.
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